Evidence map›Paper›PMID 23130126›Full record

ArticleJournal of the American Heart Association2012

Updates in cardiac amyloidosis: a review.

Sanjay M Banypersad, James C Moon, Carol Whelan, Philip N Hawkins, Ashutosh D Wechalekar

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 119 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03029026 completednot on this map

A sTudy invesTigating the Role of Occult cArdiaC Amyloid in The Elderly With Aortic Stenosis

TypeobservationalSponsorQueen Mary University of LondonRan2011 to 2021Enrolled581ConditionsCardiac Amyloidosis, Aortic StenosisArmsBaseline assessment, Transthoracic echocardiography, 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy, CT 3-5-minute post-contrast research sequences, Cardiac Magnetic Resonance
NCT07314268 recruitingnot on this mapstarted 2024, after this paper: background citation

ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers

Typeobservational_patient_registrySponsorUniversity of Sao Paulo General HospitalRan2024 to 2026Enrolled70ConditionsWild-type ATTR Amyloidosis, Amyloidosis Cardiac, Amyloidosis, Hereditary, Amyloidosis Transthyretin
3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Challenges associated with managing treatment complications in an older patient with cardiac amyloidosis.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Article
  19. A rare clinical case of systemic AA amyloidosis with cardiac involvement complicating ankylosing spondylitis: a case report.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sanjay M BanypersadNational Amyloidosis Centre, UCL Medical School, UK (S.M.B., C.W., P.N.H., A.D.W.) ; The Heart Hospital, UK (S.M.B., J.C.M.) ; University College London, UK (S.M.B., C.W.).
James C Moon
Carol Whelan
Philip N Hawkins
Ashutosh D Wechalekar

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiac amyloidosisinfiltrative cardiomypathytreatment

Identifiers

PMID23130126
PMCPMC3487372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.